#CHUhealtechConnectionDay2024 jaide team was very happy to attend the #CHUhealthtechconnection day in Lille! Camille Thiénot and Danil Savine introduced #jaide and connected with hospitals, healthcare innovators, clinicians, and industry leaders who share our vision of transforming patient care through technology. The discussions around digital health innovation, innovation funding and the future of healthcare delivery were particularly enlightening. Thanks to France Biotech and co-organizers to foster valuable conversations between startups and hospital leaders. Looking forward to building on these connections to advance healthcare innovation #HealthTech #Innovation #Healthcare #DigitalHealth #MedTech
jaide
Technologie, information et Internet
Give everyone access to world-class medical decision-making
À propos
jaide is a healthtech startup based in Paris and San Francisco Bay Area, redefining the patient-physician journey with an innovative AI clinical documentation and decision support solution. Our mission is to give access to world-class medical decision-making to everyone, starting in oncology and then expanding to other chronic diseases like diabetes, kidney failure, and heart failure.
- Site web
-
https://jaide.care
Lien externe pour jaide
- Secteur
- Technologie, information et Internet
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2024
Lieux
-
Principal
Obtenir l’itinéraire
Paris, FR
-
Obtenir l’itinéraire
Palo Alto, US
Employés chez jaide
Nouvelles
-
jaide is now an official member of France Biotech 🚀 the main trade association bringing together innovative healthtech companies in France to deploy leading healthcare solutions #healthtech #innovation #AI
-
-
A world first and the study that started it all at jaide: "Pilot applications of GPT-4 in radiation oncology: Summarizing patient symptom intake and targeted chatbot applications", published in the European Society for Radiotherapy and Oncology (ESTRO)'s leading journal in April 2023. Read it here:
-
We use GenAI so that every person has access to world-class medical decision-making. First step is getting the right diagnosis. Read Jean-Emmanuel's interview in Orange's Hello Future here:
Health: Jaide aims to reduce diagnostic errors with generative AI - Hello Future Orange
https://hellofuture.orange.com
-
Can we use GPT-4 to monitor cancer treatment toxicity in breast cancer patients? Our study was presented this summer at the American Society of Clinical Oncology (ASCO) 2024 in Chicago. Read it here:
A web-based, LLM-powered AI symptom summarization tool (ASST) for monitoring of breast cancer treatment toxicity.
ascopubs.org
-
Last week our comparative study of Large Language Models for Generating Summaries of Breast Cancer Patient-Reported Treatment Toxicities was presented by David JH Wu at the American Society for Radiation Oncology (ASTRO) annual meeting in Washington DC. We compared four leading open-source and proprietary LLMs (Mixtral-8x7B, Llama-2B, Qwen-1.5, and GPT-4) in generating summaries of patient-reported symptoms using the adapted Physician Documentation Quality Index (PDQI). Check it out here:
A Comparative Study of Large Language Models for Generating Summaries of Breast Cancer Patient-Reported Treatment Toxicities
redjournal.org
-
Our clinical trial using AI to monitor patients undergoing radiation therapy at Brazil's National Cancer Institute is now actively recruiting patients! We will soon start our trials in France and the US. More information here:
ClinicalTrials.gov
clinicaltrials.gov